nci logo
NIH
U.S. National Institutes of Health National Cancer Institute

SEER Inquiry System - View

Print Question
Question: 20120058
Status
Final

References
Source 1:   2012 Heme & Lymph Manual & DB
pgs:  
Notes:  
Source 2:  
pgs:  
Notes:  


Question
Multiple primaries--Heme & Lymphoid Neoplasms: How many primaries are to be abstracted when the patient is diagnosed with an acute neoplasm (DLBCL) per a pathology report and is subsequently diagnosed clinically with a chronic neoplasm (CLL/SLL) less than 21 days later? See discussion.

Discussion
The patient was diagnosed with an extranodal diffuse large B-Cell lymphoma and a bone marrow biopsy performed 16 days later showed no DLBCL, but demonstrated an abnormal CD5-positive B-cell population that was subsequently referred to as a CLL/SLL by a physician. The peripheral blood was negative and showed only moderate thrombocytopenia.

Does rule M9 apply for this case which indicates this is a single primary (DLBCL) because there was only one pathology specimen (a stomach biopsy) proving DLBCL and the bone marrow did not definitively identify CLL/SLL?

Answer
Abstract two primaries. Rule M13 applies to this situation. The pathology report for the DLBCL and the bone marrow for the CLL/SLL were less than 21 days apart. The physisican used the bone marrow biopsy information to diagnose CLL/SLL.

History


Last Updated
09/11/2012

Date Finalized
09/11/2012